Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Anti-Arrhythmia Agents and Cardiac Glycosides

Research Papers that Mention the Interaction

Noncardiac adverse effects and organ toxicity as well as cardiac side effects must be considered when antiarrhythmic drug therapy is initiated.
The American journal of cardiology  •  1990  |  View Paper
With ever increasing frequency potentially dangerous interactions are reported between Cardiac Glycosides and other drugs, particularly the antiarrhythmic one.
regarding the Q-D interaction; in fact, in the presence of this antiarrhythmic drug , the SDL increase significantly following the concomitant pharmacological effects of the Cardiac Glycosides.
Giornale italiano di cardiologia  •  1981  |  View Paper
Our findings reveal a new mechanism for CG‐induced Ca2+ waves and suggest a potential target for antiarrhythmic therapy in HF patients treated with CGs.
The Journal of physiology  •  2011  |  View Paper
We have previously shown that many basic drugs including antiarrhythmic drugs inhibited the hepatic uptake of cardiac glycosides into isolated rat hepatocytes, which could be a cause for the increased serum digoxin concentration.
Biopharmaceutics & drug disposition  •  1992  |  View Paper